{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-051191","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.752696+00:00","generated_at":"2026-05-20T00:42:57.802921+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nektar Therapeutics announces 1-for-15 reverse stock split effective June 8","bullets":["Board approved 1-for-15 reverse stock split effective June 8, 2025 at 11:59 p.m. ET.","Stockholders authorized reverse split ratio up to 1:40 at May 23 annual meeting; Board selected 1:15.","Split-adjusted trading begins June 9 under symbol NKTR with new CUSIP 640268306.","No fractional shares issued; rounding up for DTC participants, down for stock awards."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-051191","json":"https://secwatch.observer/filing/0001213900-25-051191.json","markdown":"https://secwatch.observer/filing/0001213900-25-051191.md","text":"https://secwatch.observer/filing/0001213900-25-051191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000121390025051191/0001213900-25-051191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000121390025051191/ea0244011-8k_nektar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T00:42:57.802921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}